We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Indian bulk drug manufacturers have requested the government and regulating authorities to bring some changes in the existing policies along with regulatory reforms to uplift the country’s API industry and work towards Aatmanirbhar Bharat.